References
- Organization, W. H., World Malaria Report 2020. 2020.
- Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001;184:770–6.
- Wongsrichanalai C, Sibley CH. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance. Clin Microbiol Infect 2013;19:908–16.
- White NJ. Antimalarial drug resistance. J Clin Investig 2004;113:1084–92.
- Burrows JN, Leroy D, Lotharius J, Waterson D. Challenges in antimalarial drug discovery. Future Med Chem 2011;3:1401–12.
- Uwimana A, Umulisa N, Venkatesan M, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis 2021;21:1120–8.
- Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant Malaria in Africa. N Engl J Med 2021;385:1163–71.
- Kalanon M, McFadden GI. Malaria, Plasmodium falciparum and its apicoplast. Biochem Soc Trans 2010;38:775–82.
- Seeber F, Soldati-Favre D. Metabolic pathways in the apicoplast of apicomplexa. Int Rev Cell Mol Biol 2010;281:161–228.
- Yeh E, Derisi JL. Chemical Rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol 2011;9:e1001138.
- Dahl EL, Rosenthal PJ. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends Parasitol 2008;24:279–84.
- Ralph SA, van Dooren GG, Waller RF, et al. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2004;2:203–16.
- Girdwood SCT, Nenortas E, Shapiro TA. Targeting the gyrase of Plasmodium falciparum with topoisomerase poisons. Biochem Pharmacol 2015;95:227–37.
- Seow F, Sato S, Janssen CS, et al. The plastidic DNA replication enzyme complex of Plasmodium falciparum. Mol Biochem Parasitol 2005;141:145–53.
- Miller ME, Parrott E, Singh R, Nelson SW. A high-throughput assay to identify inhibitors of the apicoplast DNA polymerase from plasmodium falciparum. J Biomol Screen 2014;19:966–72.
- Yang J, Trakselis MA, Roccasecca RM, et al. The application of a minicircle substrate in the study of the coordinated T4 DNA replication. J. Biol. Chem 2003;278:49828–38.
- Nessel T, Beck JM, Rayatpisheh S, et al. EXP1 is required for organization of EXP2 in the intraerythrocytic malaria parasite vacuole. Cell Microbiol 2020;22:e13168. e13168
- Wingert BM, Parrott EE, Nelson SW. Fidelity, mismatch extension, and proofreading activity of the Plasmodium falciparum apicoplast DNA polymerase. Biochemistry 2013;52:7723–30.
- Nelson SW, Zhuang Z, Spiering MM, Benkovic SJ, T4 phage replisome. Viral Genome Replication. 2009.
- Jain R, Aggarwal AK, Rechkoblit O. Eukaryotic DNA polymerases. Curr Opin Struct Biol 2018;53:77–87.
- Peterson KR, Costa FC, Fedosyuk H, et al. A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. PLoS One 2014;9:e107006.
- Sander T, Freyss J, von Korff M, Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 2015;55:460–73.
- Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.
- Ertl P, Schuffenhauer A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 2009;1:8.
- Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719–40.
- Brenk R, Schipani A, James D, et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 2008;3:435–44.
- Hann MM, Keseru GM. Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Rev Drug Discov 2012;11:355–65.
- Milton ME, Nelson SW. Replication and maintenance of the Plasmodium falciparum apicoplast genome. Mol Biochem Parasitol 2016;208:56–64.
- Vaidya AB, Mather MW. Mitochondrial evolution and functions in malaria parasites. Annu Rev Microbiol 2009;63:249–67.
- Goodman CD, Buchanan HD, McFadden GI. Is the mitochondrion a good malaria drug target? Trends Parasitol 2017;33:185–93.
- Kumar S, Bhardwaj TR, Prasad DN, Singh RK. Drug targets for resistant malaria: historic to future perspectives. Biomed Pharmacother 2018;104:8–27.
- Zhang M, Wang C, Otto TD, et al. Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Science 2018;360:eaap7847.
- Bushell E, Gomes AR, Sanderson T, et al. Functional profiling of a Plasmodium genome reveals an abundance of Essential Genes. Cell 2017;170:260–72.
- Low LM, Stanisic DI, Good MF. Exploiting the apicoplast: apicoplast-targeting drugs and malaria vaccine development. Microbes Infect 2018;20:477–83.